This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of nasal cavity and sinuses
C3_NASAL_CAVITY_SINUSES
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
224 |
4. Check minimum number of eventsNone |
224 |
5. Include endpointsNone |
224 |
6. Filter based on genotype QC (FinnGen only) |
224 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasal cavity and sinuses
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 224 | 89 | 135 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | 65.47 | 64.20 | 66.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 207
- Matched controls
- 2069
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
2219.7
124.4
108
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
251.1
69.9
68
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
167.8
59.5
60
5
UDH02
NOMESCO Finland
Rhinopharyngoscopy
21.0
55.5
87
69
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
44.4
41
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
27.0
42.3
59
30
DHB10
NOMESCO Finland
Excision of lesion of internal nose
487.5
41.7
40
*
UDM02
NOMESCO Finland
Sinoscopy
42.5
35.8
44
13
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
35.4
33
*
130
Kela drug reimbursment
Malignant tumour
11.6
35.0
70
87
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
34.3
32
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
97.7
30.8
33
*
WF002
NOMESCO Finland
Radical radiotherapy
11.5
28.1
55
63
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
309.0
27.4
27
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
25.5
24
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
80.4
25.5
28
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
24.5
23
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.8
24.3
113
412
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
23.4
22
*
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
23.4
22
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.3
22.7
84
237
R04.0
ICD-10 Finland
Epistaxis
8.3
22.5
53
82
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
35.7
22.1
28
9
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.1
21.6
40
40
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
11.8
21.3
40
41
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
21.2
20
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
29.2
21.1
28
11
H02AB02
ATC
dexamethasone; systemic
7.2
20.5
53
94
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
20.1
19
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
14.9
19.7
33
26
XX3DW
NOMESCO Finland
Time consuming IT work
6.0
19.2
58
126
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
+∞
19.0
18
*
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
19.0
18
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
19.0
18
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
15.6
19.0
31
23
A04AA02
ATC
granisetron; systemic, transdermal
9.9
18.5
38
46
DPA30
NOMESCO Finland
Sphenotomy
58.1
18.3
21
*
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
+∞
18.0
17
*
DHB40
NOMESCO Finland
Conchotomy
196.1
17.8
18
*
A04AA01
ATC
ondansetron; systemic, rectal
7.9
16.9
40
61
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
16.9
16
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
184.2
16.8
17
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.1
16.1
37
54
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.7
16.0
35
47
N02AA05
ATC
oxycodone; systemic
4.5
15.9
64
187
EEB00
NOMESCO Finland
Partial excision of maxilla
172.5
15.7
16
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.4
15.0
104
477
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
17.1
14.8
23
15
ZX090
NOMESCO Finland
Other technic of radiotherapy
12.8
14.8
26
23
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
+∞
14.8
14
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.0
14.6
37
62
L03AA02
ATC
filgrastim; parenteral
14.1
14.3
24
19
A07AA02
ATC
nystatin; oral
7.2
14.1
35
57
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.1
14.1
23
17
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.9
13.8
35
59
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
80.6
13.8
15
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
13.7
13
*
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
+∞
13.7
13
*
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
13.7
13
*
ZXC95
NOMESCO Finland
Use of surgical navigator
28.0
13.6
18
7
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.6
13.5
41
87
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
74.6
12.8
14
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.0
12.5
103
514
ZX070
NOMESCO Finland
Intensity modified radiotherapy
12.2
12.4
22
20
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.1
12.0
33
62
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
24.6
11.8
16
7
EEB10
NOMESCO Finland
Maxillectomy
+∞
11.6
11
*
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
11.6
11
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.6
11
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
37.3
11.4
14
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
21.5
11.3
16
8
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.7
11.1
32
64
JDB10
NOMESCO Finland
Percutaneous gastrostomy
23.0
10.8
15
7
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
10.9
10.8
20
20
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
63.3
10.7
12
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
63.3
10.7
12
*
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
63.3
10.7
12
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
+∞
10.5
10
*
R4190
NOMESCO Finland
Nutritional therapy
12.2
10.3
18
16
J33.0
ICD-10 Finland
Polyp of nasal cavity
10.9
10.3
19
19
Z51.5
ICD-10 Finland
Palliative care
5.6
10.0
29
58
WX402
NOMESCO Finland
General anaesthesia
3.3
9.8
53
193
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
18.6
9.5
14
8
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
31.7
9.5
12
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
31.7
9.5
12
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
104.6
9.5
10
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
23.0
9.5
13
6
DPB00
NOMESCO Finland
Partial excision of frontal sinus
+∞
9.4
9
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
9.4
9
*
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
+∞
9.4
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
9.4
76
358
ZZF00
NOMESCO Finland
Graft of adipose tissue
38.5
9.1
11
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
25.3
9.0
12
5
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
7.8
9.0
20
28
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.5
8.9
26
53
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.9
8.9
29
67
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.8
8.9
39
120
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
8.7
107
632
A04AD12
ATC
aprepitant; systemic
21.1
8.6
12
6
J33.9
ICD-10 Finland
Nasal polyp, unspecified
28.9
8.6
11
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.5
8.6
18
23
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
93.7
8.5
9
*
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
8.4
8
*
DLW99
NOMESCO Finland
Other plastic operations on nose
+∞
8.4
8
*
DKW40
NOMESCO Finland
Ligature of artery of internal nose
+∞
8.4
8
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.7
8.3
23
44
SBB10
NOMESCO Finland
Teeth copy
5.2
8.3
25
53
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.1
8.1
19
29
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.0
7.9
49
194
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.0
7.9
21
38
ZZC00
NOMESCO Finland
Graft of fascia
46.8
7.8
9
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
7.7
38
128
ZX095
NOMESCO Finland
Combined chemoradiotherapy
19.3
7.7
11
6
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
26.1
7.6
10
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
7.6
36
118
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
82.9
7.5
8
*
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
82.9
7.5
8
*
GD6AD
NOMESCO Finland
CT of chest and neck
82.9
7.5
8
*
ZZR50
NOMESCO Finland
Mucoperiosteal flap
+∞
7.3
7
*
GBB00
NOMESCO Finland
Tracheostomy
16.5
7.3
11
7
R01AD09
ATC
mometasone; nasal
2.3
7.2
96
572
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
9.3
7.2
14
16
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.3
7.1
18
31
ZXA05
NOMESCO Finland
Left side
2.4
7.0
67
340
ZXE40
NOMESCO Finland
More than seven and less than nine hours
7.6
6.8
15
21
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
17.4
6.8
10
6
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.7
47
198
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
6.6
6.6
16
26
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.6
6.6
16
26
WW500
NOMESCO Finland
Blood transfusion
4.9
6.5
20
44
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
14.9
6.5
10
7
DHB01
NOMESCO Finland
Partial excision of external nose
72.0
6.5
7
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
6.3
6.4
16
27
WX110
NOMESCO Finland
Local anesthesy
2.2
6.4
138
995
H16.0
ICD-10 Finland
Corneal ulcer
5.0
6.3
19
41
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
6.3
6
*
DLD20
NOMESCO Finland
Rhinoplasty
+∞
6.3
6
*
ZXB10
NOMESCO Finland
Medial
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
8200/3-C30.0
ICD-O-3
Adenoid cystic carcinoma of nasal cavity
+∞
6.3
6
*
8020/3-C30.0
ICD-O-3
Carcinoma, undifferentiated, NOS, of nasal cavity
+∞
6.3
6
*
R09
ICPC
Sinus symptom/complaint
4.5
6.2
21
51
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
13.1
6.1
10
8
R08
ICPC
Nose symptom/complaint other
7.6
6.0
13
18
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
7.6
6.0
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
91
163
8.72
53.70
1.9
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
26
13
22.49
34.19
1.3
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
80
198
5.73
32.51
2.5
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
75
273
3.63
17.19
2.5
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
14
13.06
17.11
1.6
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
131
676
3.26
16.84
4.1
2.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
16
17
10.06
13.60
1.3
1.1
mosm/kgh2o
287.8
272.9
1.21
16
11
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
147
877
2.97
13.51
7.7
6.7
mmol/l
1.2
1.2
0.15
121
741
(40768795) Lymph node Pathology biopsy report
14
16
9.27
11.23
1.3
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
11
11.47
11.15
1.9
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
11
11.47
11.15
2.3
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
14
9.80
10.87
1.8
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
131
802
2.53
10.39
6.9
5.7
mmol/l
1.2
1.2
0.14
124
724
(3004809) Band form neutrophils/100 leukocytes in Blood
18
32
6.03
9.92
3.4
4.1
%
1.3
0.8
0.37
11
26
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
23
55
4.55
9.16
2.7
2.5
mg/l
1.1
1.7
4.47
23
49
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
13
8.85
8.53
1.5
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
127
814
2.29
8.46
6.7
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
147
1006
2.34
8.32
17.5
9.5
e9/l
3.9
4.1
0.51
134
891
(42870588) Differential panel, method unspecified - Blood
98
582
2.22
7.65
7.5
5.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
49
215
2.64
7.55
6.2
7.4
mmol/l
0.8
1.2
0.27
37
171
(3044640) Blood type and Crossmatch panel - Blood
95
564
2.19
7.36
3.3
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
47
207
2.61
7.16
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
48
4.23
7.05
1.5
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
20
6.28
6.98
3.3
3.2
%
65.2
54.7
—
5
13
(3023368) Bacteria identified in Blood by Culture
88
520
2.14
6.79
5.9
4.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
21
5.98
6.66
1.3
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
75
421
2.17
6.56
2.7
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
33
4.80
6.56
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
29
5.08
6.54
1.8
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
120
813
2.03
6.27
7.2
5.7
%
2.2
2.8
2.37
115
755
(3002030) Lymphocytes/100 leukocytes in Blood
122
833
2.02
6.22
7.2
5.9
%
22.9
26.6
2.80
117
771
(3017143) Hepatitis C virus Ab [Presence] in Serum
38
162
2.62
6.15
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
176
2.55
6.07
1.5
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
46
221
2.36
5.77
1.5
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
7
13.32
5.63
2.1
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
126
891
1.95
5.59
6.7
5.9
e9/l
0.2
0.2
0.57
113
794
(3021440) Promyelocytes/100 leukocytes in Blood
34
144
2.60
5.56
3.6
5.2
%
0.4
0.2
0.54
23
48
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
58
3.49
5.44
1.7
2.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
73
435
2.01
5.29
13.4
6.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
32
135
2.60
5.27
3.3
5.2
%
1.8
0.4
1.79
16
36
(3006315) Basophils [#/volume] in Blood
122
865
1.90
5.26
6.4
5.6
e9/l
0.0
0.0
1.66
105
762
(3019198) Lymphocytes [#/volume] in Blood
124
884
1.90
5.25
6.4
5.7
e9/l
1.8
1.8
0.05
109
791
(3018010) Neutrophils/100 leukocytes in Blood
117
821
1.89
5.18
6.3
5.6
%
60.7
58.1
1.25
112
765
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
31
4.39
5.16
1.3
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
121
864
1.87
5.02
6.4
5.6
e9/l
0.6
0.6
0.22
104
759
(3018418) pH of Serum or Plasma
83
525
1.92
5.02
6.0
3.8
ph
7.4
7.4
0.17
22
98
(3017181) Myelocytes/100 leukocytes in Blood
35
158
2.44
5.01
3.6
5.0
%
1.8
1.0
0.72
22
55
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
103
2.72
4.83
1.5
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
29
4.32
4.69
1.3
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
29
4.32
4.69
2.0
7.3
—
171.6
—
0
5
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
30
133
2.45
4.46
1.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
41
209
2.18
4.43
1.6
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
70
437
1.88
4.31
1.4
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
36
3.77
4.27
1.6
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
36
3.77
4.27
1.3
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
136
1642
0.56
4.07
3.8
4.8
mmol/l
1.4
1.4
0.29
124
1486
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
7
10.27
4.04
2.6
2.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
54
3.11
3.93
3.1
2.0
u/ml
0.2
0.4
0.81
11
26
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
38
200
2.08
3.78
4.1
3.3
umol/l
8.6
9.2
0.06
33
175
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
200
2.08
3.78
2.5
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
27
124
2.34
3.72
2.0
2.2
g/l
9.5
10.2
0.46
27
112
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
17
5.47
3.55
1.2
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
200
2.02
3.42
2.5
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
26
122
2.28
3.42
4.2
4.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
27
3.83
3.39
8.1
4.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
140
1651
0.59
3.35
3.8
4.8
mmol/l
4.7
4.5
0.89
130
1510
(3003181) Sodium [Moles/volume] in Urine
11
33
3.45
3.23
1.0
1.4
mmol/l
62.9
63.5
0.02
11
33
(3023410) Appearance of Cerebral spinal fluid
8
15
5.49
3.22
2.4
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
79
554
1.66
3.11
2.9
3.2
e6/l
28.7
177.1
0.70
61
432
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
34
3.35
3.10
1.4
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
185
1.99
3.09
5.7
3.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
12
5.98
3.04
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
95
2.34
3.00
7.7
9.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
53
337
1.75
2.97
4.1
2.9
mmol/l
2.5
2.5
1.34
48
296
(3025159) Blasts/100 leukocytes in Blood
27
137
2.10
2.95
4.0
5.3
%
0.0
0.2
0.65
16
42
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
136
1596
0.62
2.88
3.6
4.3
mmol/l
1.4
1.3
0.97
122
1443
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
132
2.10
2.84
4.0
2.5
ml/min/173m2
67.5
63.7
0.21
11
54
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
23
4.03
2.80
2.0
1.7
ug/l
15.8
17.1
—
9
23
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
147
1691
0.62
2.79
4.0
5.3
mmol/l
2.7
2.7
0.26
133
1528
(3021589) Normoblasts [#/volume] in Blood
100
760
1.57
2.76
13.4
10.2
e9/l
0.0
0.0
0.21
84
631
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
14
5.12
2.75
2.6
2.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
36
576
0.55
2.72
4.4
4.0
mg/mmol
7.2
7.4
0.02
22
376
(3009508) Creatinine [Moles/volume] in Urine
35
563
0.55
2.69
3.4
3.1
mmol/l
8.0
7.9
0.05
30
462
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
282
1.75
2.64
2.7
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
85
628
1.57
2.63
3.2
3.9
e6/l
23.2
87.1
1.72
63
461
(3026389) Candida sp identified in Specimen by Organism specific culture
8
20
4.11
2.59
1.8
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
20
4.11
2.59
1.3
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
11
5.57
2.56
1.8
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
11
5.57
2.56
1.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
11
5.57
2.56
1.0
1.1
mmol/l
4.2
1.8
—
6
11
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
16
4.48
2.49
1.9
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
55
370
1.64
2.49
2.6
2.7
e6/l
5.8
4.7
0.31
48
326
(3030467) Casts [#/volume] in Urine by Automated count
70
501
1.58
2.46
2.6
3.1
e6/l
0.3
0.6
0.92
51
379
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
17
335
0.47
2.43
1.1
1.3
u/ml
8.0
1.7
—
6
94
(3000991) Gas panel - Venous blood
28
155
1.92
2.43
6.3
8.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
27
3.43
2.42
1.0
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
86
647
1.53
2.42
2.7
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
171
0.33
2.40
1.7
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
22
3.73
2.38
1.0
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
98
763
1.51
2.33
6.8
8.5
inr
1.3
1.3
0.05
28
223
(1761868) Lipid panel - Serum or Plasma
37
566
0.59
2.32
3.0
3.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
74
545
1.53
2.27
2.1
2.1
u/l
174.5
249.3
0.65
69
517
(36304419) Bacteria [Presence] in Urine
66
475
1.55
2.24
2.5
3.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
9
5.65
2.22
2.2
6.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
36
544
0.60
2.13
3.5
3.3
mg/l
3029.3
159.2
0.75
27
364
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
26
3.15
2.03
4.6
2.2
e9/l
4.0
5.0
—
8
26
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
49
340
1.56
1.94
3.5
3.5
ng/l
396.7
137.8
0.62
42
277
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
34
2.71
1.88
1.1
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
28
2.92
1.88
6.6
2.9
%
66.0
56.5
—
8
28
(3023419) Bacteria identified in Sputum by Culture
7
23
3.11
1.81
2.0
2.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
47
2.41
1.80
1.7
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
36
2.56
1.76
7.0
4.8
—
—
—
0
0
(3026782) Osmolality of Urine
50
357
1.52
1.74
2.6
3.1
mosm/kgh2o
537.6
569.2
0.43
43
301
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
16
287
0.52
1.73
1.1
1.3
iu/ml
24.4
38.0
—
5
91
(3044889) 12 lead EKG panel
140
1214
1.41
1.68
4.2
4.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
91
1.94
1.65
2.4
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
14
3.63
1.62
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
452
0.64
1.55
2.5
3.1
ug/l
0.8
0.8
0.02
24
302
(3028026) IgM [Mass/volume] in Serum or Plasma
18
103
1.81
1.46
1.9
1.6
g/l
1.4
1.8
0.21
18
91
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
16
3.17
1.44
3.2
2.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
25
160
1.63
1.39
2.0
2.8
e9/l
67.1
71.5
0.26
20
124
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
243
0.55
1.38
4.3
4.8
%
31.2
31.5
—
9
152
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
47
2.18
1.36
2.0
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
38
0.00
1.35
0.0
1.2
—
0.8
—
0
33
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
11
54
2.09
1.35
6.5
3.9
mg/l
90.4
31.0
0.58
11
45
(40760892) CBC W Ordered Manual Differential panel - Blood
51
385
1.42
1.34
4.3
5.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
181
1672
1.43
1.30
28.6
15.3
mg/l
26.6
24.5
0.41
166
1353
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
150
1642
0.74
1.29
4.3
5.0
mmol/l
6.1
6.1
0.05
136
1482
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
18
2.82
1.29
1.6
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
44
2.09
1.28
1.6
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
63
1.96
1.25
1.3
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
25
2.44
1.25
2.2
3.5
—
—
—
0
0
(3036489) Thrombin time
11
56
2.01
1.24
2.2
1.9
s
20.1
21.4
0.69
11
50
(3026493) Urate [Moles/volume] in Serum or Plasma
60
472
1.37
1.24
3.9
2.8
umol/l
325.0
7992.1
2.48
55
390
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
14
79
1.82
1.20
2.6
4.0
mmol/l
26.9
23.9
4.97
14
69
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
26
2.34
1.19
2.5
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
26
2.34
1.19
2.5
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
145
1586
0.76
1.16
5.0
6.5
mmol/mol
40.4
40.8
0.17
133
1461
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.53
1.15
2.2
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
30
2.38
1.13
1.1
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
8
40
2.04
1.13
2.5
1.6
—
4.6
—
0
14
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
41
1.99
1.10
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.41
1.09
1.6
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
32
2.22
1.09
1.1
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
136
1219
1.29
1.08
4.5
3.8
pmol/l
14.2
14.9
2.26
131
1075
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
46
2.00
1.05
2.2
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
22
2.30
1.04
4.2
3.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
34
2.09
1.04
2.3
1.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
10
54
1.89
0.98
7.0
3.9
mg/l
19.8
192.5
—
10
45
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
30
0.00
0.98
0.0
3.4
—
28.7
—
0
9
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
28
2.17
0.92
1.0
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
24
169
1.47
0.92
2.5
4.0
mmol/l
3.2
1.9
1.56
24
122
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
62
738
0.78
0.90
2.0
2.0
pmol/l
84.6
92.7
0.79
34
370
(3012544) pH of Venous blood
25
180
1.44
0.86
2.5
3.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
114
0.51
0.85
1.2
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
24
173
1.43
0.83
2.5
4.0
kpa
6.0
5.6
1.28
24
163
(3031040) Bacteria [#/volume] in Urine by Automated count
125
1133
1.23
0.81
3.9
4.4
e6/l
391.9
614.1
—
7
22
(3023103) Potassium [Moles/volume] in Serum or Plasma
187
1775
1.32
0.80
28.3
17.9
mmol/l
4.0
4.0
1.80
182
1722
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
2.6
—
43.0
—
0
25
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
32.7
—
0
7
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
107
1.53
0.78
2.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
157
1464
1.24
0.75
24.9
16.3
%
37.3
39.9
2.72
113
971
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
24
2.11
0.75
1.8
2.7
nmol/l
4.9
3.1
—
5
24
(3019225) pH of Specimen
24
177
1.40
0.74
4.4
4.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
57
1.60
0.72
1.3
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
26
1.94
0.71
1.6
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
129
1184
1.21
0.70
3.9
4.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.6
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
46
380
1.26
0.68
1.7
1.7
mg/l
2.2
1.3
0.80
38
295
(3019230) Fractional oxyhemoglobin in Venous blood
5
28
1.80
0.66
1.2
2.4
%
76.1
61.6
—
5
28
(3004588) Protein electrophoresis panel - Serum or Plasma
18
129
1.43
0.66
4.4
2.0
—
—
—
0
0
(3013512) EKG study
48
568
0.80
0.65
3.7
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
168
1592
1.22
0.61
26.0
14.7
ml/min/173m2
83.2
78.0
2.93
149
1310
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
115
0.60
0.59
1.7
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
35
1.73
0.58
1.2
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
60
1.52
0.55
2.2
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
56
639
0.84
0.53
4.4
4.5
%
23.0
21.7
0.21
30
314
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
64
1.42
0.52
3.3
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
40
1.51
0.52
1.2
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
16
212
0.74
0.51
1.6
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
46
1.54
0.49
3.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
138
1.33
0.47
1.7
3.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
19
241
0.77
0.46
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
50
1.41
0.45
1.6
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
91
0.65
0.43
1.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
31
1.63
0.43
1.4
3.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
31
1.63
0.43
1.4
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
33
1.53
0.41
1.8
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
4.0
—
104.8
—
0
18
(1761482) Bacteria [#/volume] in Urine by Culture
8
61
1.32
0.40
2.6
5.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
80
1.39
0.39
5.8
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
66
1.38
0.39
6.8
1.9
g/l
40.3
37.8
—
9
56
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
72
787
0.87
0.39
4.0
5.2
ug/l
3.4
2.9
0.13
67
698
(3021901) Oxygen saturation in Capillary blood
5
36
1.40
0.38
2.4
2.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
19
152
1.27
0.38
4.5
2.3
g/l
65.6
66.5
0.21
19
137
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
9
68
1.34
0.38
7.2
2.0
g/l
1.2
0.5
—
9
62
(3013707) Erythrocyte sedimentation rate by Westergren method
134
1272
1.13
0.38
4.8
4.2
mm/h
16.7
12.6
2.08
129
1161
(3020891) Body temperature
10
72
1.41
0.37
1.9
4.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
37
1.36
0.37
1.8
3.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
288
1.17
0.31
2.6
2.8
e6/l
0.5
1.7
1.88
18
167
(3052851) Hemolysis interference index of Serum or Plasma
7
54
1.31
0.30
2.6
3.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
14
112
1.27
0.29
2.1
3.4
mmol/l
3.7
1.7
—
9
81
(3020564) Creatinine [Moles/volume] in Serum or Plasma
183
1785
1.14
0.28
31.5
18.3
umol/l
75.1
81.2
3.69
183
1785
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
157
1520
1.11
0.27
5.0
4.5
mu/l
2.1
2.0
0.58
145
1352
(3001122) Ferritin [Mass/volume] in Serum or Plasma
65
699
0.90
0.26
2.0
2.6
ug/l
200.4
141.9
0.85
60
630
(3021960) Folate [Moles/volume] in Serum or Plasma
49
447
1.12
0.26
1.6
1.6
nmol/l
19.8
20.9
0.20
43
368
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
22
255
0.85
0.26
1.6
2.3
%
21.8
22.4
0.07
17
220
(3000492) Spirometry study
18
151
1.21
0.26
1.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
87
921
0.91
0.26
2.8
2.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
81
857
0.91
0.23
3.6
3.9
estimate
0.0
0.0
0.00
20
158
(3029937) Albumin [Presence] in Urine by Test strip
51
470
1.11
0.23
3.8
4.0
estimate
0.0
0.0
0.00
20
161
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.8
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
80
844
0.92
0.21
4.5
5.3
estimate
0.0
0.0
0.00
21
169
(3011397) Hemoglobin [Presence] in Urine by Test strip
34
375
0.89
0.21
2.0
3.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
89
1.25
0.21
1.8
3.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
24.2
—
0
12
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
14
117
1.21
0.21
2.2
3.4
—
7.4
—
0
14
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4062490)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
52
1.16
0.19
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
91
1.22
0.18
2.4
4.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
22
246
0.88
0.17
5.7
23.8
inr
1.3
1.3
—
5
33
(3019309) Folate [Moles/volume] in Red Blood Cells
39
361
1.10
0.16
1.5
1.7
nmol/l
1102.9
1187.8
0.27
30
268
(40761511) CBC panel - Blood by Automated count
178
1749
1.09
0.16
22.3
14.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
79
0.75
0.16
1.0
2.3
u/l
26.7
40.2
—
6
70
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
72
752
0.94
0.14
3.7
4.0
ng/l
865.2
44.3
0.50
54
551
(3026008) Bacteria identified in Urine by Culture
49
519
0.93
0.14
2.8
3.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
10
84
1.20
0.14
1.2
1.3
u/ml
208.6
195.1
—
10
76
(40761536) Microorganisms panel - Urine sediment
16
142
1.14
0.13
7.0
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
64
665
0.95
0.10
3.8
4.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
62
0.80
0.08
1.6
2.0
—
—
—
0
0
(4010399)
11
123
0.89
0.08
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
80
0.87
0.07
1.4
2.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
87
1.04
0.07
2.0
2.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
187
1855
1.05
0.06
36.7
22.5
e9/l
243.4
242.9
0.03
180
1798
(3035350) Ketones [Presence] in Urine by Test strip
82
837
0.97
0.06
3.5
3.9
estimate
0.0
0.0
0.00
20
165
(3022621) pH of Urine by Test strip
12
110
1.10
0.05
1.8
2.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
187
1857
1.04
0.05
36.7
22.5
e12/l
4.2
4.5
9.81
180
1795
(3010813) Leukocytes [#/volume] in Blood
187
1857
1.04
0.05
36.7
22.6
e9/l
7.0
6.7
0.56
179
1795
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
111
1.09
0.04
1.6
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
49
479
1.03
0.03
4.2
3.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
46
452
1.02
0.01
1.8
2.0
mg/l
3.1
3.0
0.05
38
383
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68
672
1.02
0.01
1.9
2.3
nmol/l
71.6
74.9
0.53
60
590
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
106
0.94
0.01
1.3
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
15
148
1.01
0.00
2.3
3.0
kpa
4.9
4.3
0.44
15
137
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
108
1076
1.01
0.00
3.4
3.4
u/l
53.9
51.5
0.12
103
1009
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
23
227
1.01
0.00
1.1
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
307
1.01
0.00
2.5
2.6
e6/l
0.6
0.9
0.31
15
183
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
185
0.97
0.00
1.3
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
107.0
—
0
5
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.2
—
0
6
(4211845)
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
24.6
—
1251.1
—
0
9
(44813793)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
1.2
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
6
0.00
0.00
0.0
1.2
—
4.0
—
0
6
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
18.8
—
0
5
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
0.00
0.0
35.6
—
115.8
—
0
5
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
13.8
—
878.0
—
0
9
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
76
0.92
0.00
1.4
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
8.9
—
0
9
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
74.7
—
0
9
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
28.0
—
0
8
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
146.8
—
0
9
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
100
1.00
0.00
1.4
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
12.9
—
0
5
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
230
1.00
0.00
13.2
7.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
49
1.02
0.00
2.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
12.6
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NASAL_CAVITY_SINUSES – Malignant neoplasm of nasal cavity and sinuses
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).